Introduction {#S0001}
============

The aim of the Danish Blood Donor *Staphylococcus aureus* Carriage Study (DBDSaCS) established in 2014 is to investigate the colonization of *S. aureus* among healthy individuals and to establish a prospective cohort and biobank for research purposes. The DBDSaCS originates from the Danish Blood Donor Study (DBDS, [www.dbds.dk](http://www.dbds.dk)).[@CIT0001] The DBDSaCS is unique allowing investigation of the mechanisms involved in *S. aureus* carriage and the influence of carriage on health and the risk of disease among otherwise healthy individuals.

*S. aureus* is a bacterium that colonizes the skin and mucous membranes of humans and animals; up to 50% of the healthy adult population are carriers of *S. aureus* in the nose either intermittently or persistently.[@CIT0002],[@CIT0003] The anterior nares are believed to be the most important colonization site for *S. aureus*.[@CIT0004]--[@CIT0006] However, several studies have highlighted the importance of throat colonization, as throat carriage frequency has been reported to range between 30% and 47%.[@CIT0007]--[@CIT0009] Rapid diagnostic tests are often used to determine *S. aureus* carriage because molecular diagnostic methods, when compared to culture methods, can reduce the "turnaround time" in the laboratory and, in the case of methicillin-resistant *S. aureus* (MRSA), reduce costs by avoiding any unnecessary isolation days.[@CIT0010] However, culture methods remain highly important as molecular tests have been shown to produce both false-negative and false-positive results.[@CIT0011],[@CIT0012] Culture methods are furthermore less expensive and central for susceptibility testing and surveillance.

Apart from being a commensal in the nasal and throat cavity, *S. aureus* is also a potent pathogen which may cause a variety of diseases, ranging from simple skin infections to life-threatening soft tissue infections, deep abscesses, arthritis, osteomyelitis, endocarditis, and bacteremia.[@CIT0013] *S. aureus* is a dominant nosocomial pathogen in both community and health care settings worldwide.[@CIT0014],[@CIT0015] Moreover, *S. aureus* is the second most frequent pathogen in bloodstream infections in Denmark and accounted for 18% of all bloodstream infections in 2017 ([www.danmap.org](http://www.danmap.org)).[@CIT0016] Invasive *S. aureus* infections are associated with a high morbidity and mortality, and although colonization itself is harmless, carriers are at increased risk of infection.[@CIT0002],[@CIT0003],[@CIT0017]--[@CIT0021] In case of resistance toward various antibiotics, such as in MRSA which is resistant to most of the beta-lactam group of antibiotics complicates treatment of *S. aureus* infections and constitute an increasing burden on health care resources.[@CIT0015],[@CIT0022] Hence, knowledge of *S. aureus* carriage and effective measures to prevent *S. aureus* infections are important.

The mechanisms involved in the transition from carriage to infection are not completely understood but infection is probably a result of both bacterial and host factors.[@CIT0023],[@CIT0024] The causal relation between *S. aureus* nasal carriage and infection is supported by the fact that decolonization of the nose by nasal application of mupirocin among carriers of *S. aureus* prior to surgery reduces the risk of subsequent infection.[@CIT0025],[@CIT0026] However, the effect of nasal carriage among healthy individuals on the risk of subsequent infection is not known and therefore there is a need for a population-based study addressing this.

There are only a few population-based cohort studies on *S. aureus* colonization. The Tromso Staf and Skin Study in Norway,[@CIT0027],[@CIT0028] The Study of Health in Pomerania in Germany,[@CIT0029] and the Generation R Study in The Netherlands[@CIT0030] are all examples of sound population-based studies that have addressed *S. aureus* colonization and determinants for *S. aureus* colonization. However, the DBDSaCS is unique because participants are healthy blood donors, a selected group which is generally healthier than the background population, because they must comply with strict criteria to be blood donors. Furthermore, we can assess outcomes in the Danish health registers allowing for complete follow-up with regard to diagnosis codes among both inpatient and outpatient hospital contacts as well as redeemed prescriptions, also after the participants have seized to donate blood. Our participants will be followed for 25 years. Furthermore, genotyping of all participants in the DBDSaCS for more than 650,000 single-nucleotide polymorphisms (SNP) is ongoing. This provides exceptional possibilities in the future investigation of host factors as determinants for *S. aureus* colonization in addition to addressing bacterial colonization determinants. The DBDSaCS allows us to investigate the mechanisms involved in *S. aureus* carriage and the influence of carriage on health and the risk of disease.

Here, we describe the setting, organization, and content and present the cohort and results of colonization for quality assurance from the first 6082 participants.

Objectives {#S0002}
==========

The overall aim of the DBDSaCs is to establish a prospective cohort and biobank to investigate the epidemiology, predictors, underlying mechanisms, and associated risk factors of *S. aureus* nasal colonization/carriage and to examine the effect of *S. aureus* nasal carriage on health outcomes. Specifically, the objectives of the DBDSaCS can be categorized as follows: To determine the prevalence of *S. aureus* nasal carriage among healthy adults and to examine whether carriage is associated with demographic factorsTo identify genetic and immunological predictors and risk factors for *S. aureus* nasal carriageTo investigate whether *S. aureus* carriage is associated with inflammatory and endocrine markers in serum or plasmaTo examine the impact of *S. aureus* carriage in healthy individuals on the risk of subsequent diseaseTo examine the nasal microbiome among healthy adults and whether genetic or demographic factors are associated with the composition of microorganisms

Study population and setting {#S0003}
============================

The DBDSaCS is an ongoing multicenter, multiregional, prospective cohort of blood donors. Our study was initiated in January 2014 at Aarhus University Hospital in collaboration between the Department of Clinical Immunology and Department of Clinical Microbiology.

The DBDSaCS has recruited participants among participants in the Danish Blood Donor Study (DBDS) at multiple blood donation facilities in the Central Denmark Region from January 2014 and from September 2014 in the North Denmark Region. DBDSaCS will include participants from the Zealand Region from August 2019. The DBDS is an ongoing nationwide, public-health study and biobank launched 1 March 2010 ([www.dbds.dk](http://www.dbds.dk)). So far, more than 125,000 donors from all five administrative regions of Denmark have been included. Blood donors aged from 18 to 67 years (70 years from 1 January 2019) are invited to participate. EDTA plasma samples from each donation and whole blood for DNA purification are stored in a biobank. Participants have consented in merging study data with data from public registers. Blood donation requires compliance with strict criteria. Donation is not allowed if the donor received antibiotics within the preceding 4 weeks. Recent traveling in areas where malaria can be found (most of Africa, South-East Asia, and South America) leads to deferral for 6 months and traveling to areas where flaviviruses are found (most areas outside of Northern Europe) leads to deferral for 4 weeks. Implicitly, all participants were healthy, nonpregnant, and nonlactating adults testing negative for HIV, hepatitis B, and C.[@CIT0001],[@CIT0031]--[@CIT0033]

Blood donors return repeatedly for donation; at the time of donation, they are asked to participate in the DBDSaCS and consenting donors complete a questionnaire, a nasal swab is taken by trained health care personnel, and plasma samples are stored. Further, 1385 DBDSaCS participants were at subsequent donations asked to repeat completion of the same questionnaire, and nasal swab and blood samples were taken again. A single throat swab concurrent with a nasal swab was sampled among the first 262 participants included in the study. Only 0.72% declined to participate in the study. [Figure 1](#F0001){ref-type="fig"} depicts a flowchart of the DBDSaCS cohort consisting of the following:DBDSaCS, Central Denmark Region: 5588 participants (91.9%) recruited in the donation facility at Aarhus University Hospital (4989, 82.0%), primarily, and in the donation facility at Herning-Holstebro Hospital (599, 9.9%) in the western part of Central Denmark RegionDBDSaCS, North Denmark Region: 494 participants (8.1%) recruited from the blood center of Aalborg University Hospital.Figure 1Flowchart of the Danish Blood Donor *S. aureus* Carriage Study cohort.

See [Table 1](#T0001){ref-type="table"} for characteristics of participants in DBDSaCS in comparison with blood donors not participating in the study. We defined nonparticipants as Danish blood donors donating whole blood or plasma from January 1^st^ 2014 to April 1^st^ 2019 from the Scandinavian Donations and Transfusions Database (SCANDAT), a database including all electronically recorded Danish and Swedish blood donations since the 1980s and 1970s, respectively. For characteristics of nonparticipants, one donation from each donor was randomly sampled as the index donation. Table 1Characteristics of the DBDSaCS cohort (n=6082) in comparison with the national blood donor cohort (n=234,836)DBDSaCS^a^Blood donors not participating^a^WomenMenWomenMenN (%)2683 (44.1)3399 (55.9)126,738 (54.0)108,098 (46.0)Age, years36.7 (25.7--50.2)39.1 (28.5--50.9)34.6 (24.6--48.0)39.5 (28.0--51.1)Age strata (%) 18--2521.612.326.516.8 26--3526.029.324.224.0 36--4517.521.718.920.9 46--5519.219.818.121.3 56--6715.717.012.417.1Hemoglobin, mmol/L8.5 (8.2--8.8)9.4 (9.1--9.7)8.5 (8.1--8.8)9.4 (9.1--9.8)Donations during previous: 1 year2 (2--3)3 (2--4)2 (1--3)2 (1--3) 3 years5 (4--7)6 (4--9)3 (1--5)4 (2--7) 5 years7 (5--10)9 (6--12)4 (2--8)7 (3--11)Weight, kg70 (63--80)^b^84 (76--93)^b^NANAHeight, cm170 (165--174)^c^183 (178--187)^c^NANABMI, kg/m^2^24.3 (22.1--27.5)^d^25.2 (23.3--27.4)^d^NANACurrent smoker (%)11.8^e^12.6^e^NANAShort form-12 Physical Component Score56.6 (53.8--57.8)^f^56.6 (54.1--57.9)^f^NANA Mental Component Score55.1 (51.2--57.7)^f^55.8 (52.8--57.7)^f^NANA[^2][^3]

Inclusion of participants is performed year-round except in July due to reduced capacity. The number of included participants per calendar month and their carrier state is presented in [Figure 2](#F0002){ref-type="fig"}.Figure 2Bar chart illustrating the number of participants included by calendar month and their carrier status. Orange (or lower pillar) = *S. aureus* positive; Green (or upper pillar) = *S. aureus* negative.

Oral and written informed consent was obtained from all participants. The DBDSaCS project (1-10-72-307-13) and the DBDS (M-20090237) were approved by the Scientific Ethical Committee in the Central Denmark Region. The DBDS GWA study was approved by the Danish National Committee on Health Research Ethics (1700407). The establishment of the biobank was approved by the Danish Data Protection Agency (2007-58-0015). This study was conducted in accordance with the Declaration of Helsinki.

Microbiological methods {#S0003-S2001}
-----------------------

*S. aureus* colonization was determined by a single nasal swab taken at study inclusion when participants donated blood. Until April 2019, 6082 donors have been included. Samples from the first 2217 participants were cultured using the two-step method. Among the 2217 participants with samples from the nose and using the two-step method, 262 participants were also sampled from the throat.

Samples were taken with sterile Copan ESwabs (Copan, Brescia, Italy). The samples from the anterior nares were obtained by a single swab rotated five times in both nostrils while applying a gentle pressure. Throat samples were obtained by rotating a single swab over the surface of both tonsils and the posterior wall of the pharynx while applying a gentle pressure. Samples were stored at +4°C before culturing. Within 24 hrs, all samples were cultured initially using a two-step method later replaced by a one-step method.

In the two-step method, the flocked swab (FLOQSwab, Copan) was first streaked on *S. aureus* chromID agar plates (SAID) (bioMerieux, Marcy- l'étoile, France) and then submersed into Tryptase Soy Broth (TSB) (SSI Diagnostica, Hillerød, Denmark). The SAID plates and TSB enrichment broths were incubated for 18--24 hrs at 35--37°C. Growth of green colonies on SAID was confirmed as being *S. aureus* with matrix-assisted laser desorption/ionization time-of-flight mass spectrometer (Bruker Microflex, LT/SH system; Bruker Daltonik GMbH, Bremen, Germany). From samples without *S. aureus* after primary culture, the TSB enrichment broths were subsequently subcultured on SAID and incubated for another 18--24 hrs at 35--37°C. *S. aureus* determination was performed as described above.

In the one-step culture method, TSB enrichment broth was inoculated with the flocked swab and incubated for 18--24 hrs at 35--37°C. All samples were subsequently subcultured from the enrichment broth on SAID and incubated for another 18--24 hrs at 35--37°C; then, *S. aureus* determination was performed as described above. The advantage of the one-step method is a shortening of the cultivation process by 1 day and a reduction of the amount of plates used.

Data collection and variables {#S0004}
=============================

Questionnaires {#S0004-S2001}
--------------

Participants filled out a two-page questionnaire with items including the Short Form-12 (SF-12) health-related quality of life (HRQL) survey, smoking status, anthropometric measurements, and physical activity at work and in leisure time. Questionnaires were double entered. From May 2017, participants completed the questionnaire electronically at enrolment as described previously.[@CIT0034] In addition, between June 2015 and May 2018, a total of 4488 participants in the DBDSaCS completed a comprehensive electronic questionnaire version 2 in the DBDS; among these, donors completed questions regarding allergy, asthma, and place of upbringing (based on standardized questions from the European Community Respiratory Health Survey questionnaire), hidradenitis suppurativa,[@CIT0035] restless leg syndrome,[@CIT0036] attention deficit hyperactive syndrome, and migraine.[@CIT0037]

The SF-12 is an abbreviated version of Short Form-36 (SF-36) developed for population surveys for determining general health outcomes, described in detail previously.[@CIT0038],[@CIT0039] Briefly, SF-12 consists of 12 items providing a Physical Component Score and a Mental Component Score, and these scores explain more than 80% of the variance in the original eight SF-36 scores,[@CIT0040] higher scores indicating better HRQL. For missing values in SF-12 items, an imputation algorithm was used as previously described.[@CIT0038],[@CIT0041]

Body mass index (BMI) was calculated as weight divided by height squared (kg/m^2^). We categorized each participant according to BMI using WHO definitions: BMI \<18.5 kg/m^2^ (underweight), 18.5≤ BMI \<25 (normal weight as reference group), 25≤ BMI \<30 (overweight), and BMI ≥30 (obese)[@CIT0042] Current smokers (yes/no) were defined when answering either "Yes, but less than 1 cigarette/cheroot/pipe per day" or "Yes, more than 1 cigarette/cheroot/cigar/pipe per day" and cumulative tobacco consumption in pack years as defined elsewhere.[@CIT0038] Physical activity at work and in leisure time were categorized as high vs low, see the definition from the previous study in DBDS.[@CIT0038],[@CIT0043]

Biochemical material and measures {#S0004-S2002}
---------------------------------

### Biobank {#S0004-S2002-S3001}

A biobank with plasma samples (frozen at −20°C), Copan ESwab transport media, and *S. aureus* isolates (frozen at −80°C) was established for the entire cohort. The Copan ESwab transport media were frozen within 24 hrs after they were obtained. Our study and biobank serve as a platform for future research in predictors, underlying mechanisms, and associated risk factors of *S. aureus* nasal carriage, but potentially also for research purposes on other nasal pathogens. Various biomarkers will be of interest to measure, including immunological and inflammatory markers, markers of iron metabolism, and endocrine markers ([Table 2](#T0002){ref-type="table"}). Table 2Samples and data collected in DBDSaCSNo. of samples/measurementsMaterialBaseline plasma samples12,1645 mL EDTA plasma from the first inclusion in DBDSaCSFollow-up plasma samples41805 mL EDTA plasma from follow-up in DBDSaCSBaseline nasal swabs6082Nasal swabs from anterior nares, both nostrilsFollow-up nasal swabs, 2nd visit1385Nasal swabs from anterior nares, both nostrilsFollow-up nasal swabs, 3rd visit459Nasal swabs from anterior nares, both nostrilsFollow-up nasal swabs, 4th visit165Nasal swabs from anterior nares, both nostrilsFollow-up nasal swabs, 5th visit76Nasal swabs from anterior nares, both nostrilsThroat swabs262Throat swabs from oropharynx and both tonsils*S. aureus* isolates3465*S. aureus* isolates after culturing from positive nasal and throat swabsQuestionnaire data, DBDSaCS8067Anthropometric, health-related quality of life, smoking, and physical activity dataQuestionnaire data, DBDS version 24488Asthma, allergy, upbringing, and screening questions of hidradenitis suppurativaImmunological markers Complete blood count7886Hemoglobin, white blood cells, hemotocrit, platelets, Leukocyte subsets6742Blood cell counts of basophil, eosinophil, lymphocytes, monocytes, and neutrophil Ferritin724Marker of iron metabolism Genetics3133Approx. 650,000 single nucleotide polymorphisms Nasal microbiome2161Nasal microbiome characterization using 16S rRNA gene-based sequencing Danish registers linkage6082Entire cohort linked to NPR, DNPR, and socioeconomic data at Statistics Denmark[^4]

### Immunological markers {#S0004-S2002-S3002}

Erythrocyte and leukocyte subsets were measured with Sysmex^®^ XT-1800i (Sysmex Corp., Kobe, Japan) on a blood sample taken prior to blood donation among the included donors as a part of the daily routine in the Central Denmark Region Blood Center including: hemoglobin, hematocrit, mean erythrocyte volume, mean erythrocyte hemoglobin concentration, white blood cells, platelet counts, basophil, eosinophil, lymphocyte, monocyte, and neutrophil. At this point, ferritin measurement is available for 605 participants and measurements of remaining participants are ongoing.

### Genetics {#S0004-S2002-S3003}

A total of 110,000 participants in the DBDS are genotyped for approximately 650,000 SNPs using the Infinium Global Screening Array (Illumina Inc., San Diego, CA) in collaboration with deCODE Genetics (Reykjavik, Iceland). A further \>8 million SNPs have been imputed by use of newly sequenced reference genomes. Standard quality control is applied, thus variants that fail Hardy--Weinberg equilibrium and samples with low genotype yield (less than 98%) will be excluded from the analysis.[@CIT0044] Currently, genetic data on a subgroup of DBDSaCS participants (n=3133) are available. Genetic data are stored and available for analysis at Computerome (Technical University of Denmark, Lyngby).

### Nasal microbiome {#S0004-S2002-S3004}

The nasal bacterial density has been measured in 2161 nasal samples using a broad-coverage quantitative polymerase chain reaction and the nasal microbiota composition has been characterized by 16S rRNA gene-based sequencing. These data are currently being processed.

Registers {#S0004-S2003}
---------

In Denmark, the unique personal identification number given to each citizen at birth, immigration, and used in public registers enables continuous linkage of data of the entire cohort with the nationwide Danish public registers hosted by Statistics Denmark ([www.dst.dk](http://www.dst.dk)).

Past and future contacts with hospitals in Denmark are available through the Danish National Patient Register (NPR), thus making follow-up of the entire cohort on development of diseases possible. This register was established in 1977[@CIT0045],[@CIT0046] and holds records of all hospital contacts in Denmark with information on dates of admission and discharge, and diagnostic information based on the International Classification of Diseases, Eighth Revision (ICD-8) until 1993 and Tenth Revision (ICD-10) from 1994 until present.

Information on redeemed prescriptions from all Danish pharmacies is available from The Danish National Prescription Register, which was established in 1994. This information includes the unique personal identification number of the patient, the type of drug according to the Anatomical Therapeutic Chemical classification system, dosage, pack size, and the date of redeemed prescription.

Data informatics, linkage, and updates {#S0005}
======================================

Master data of all participants were recorded in the Danish blood bank system ProSang 9.1 (CSAM Health, Oslo, Norway). This system holds records of following main variables: personal identification number, a unique identification number for each donation contact, contact information, donation history, laboratory test (blood type, hemoglobin, erythrocyte, and leukocyte subsets), and screening results (HIV, hepatitis B and C).

Microbiology test results were recorded in MADS laboratory information system (Dept. of Clinical Microbiology Aarhus University Hospital, Aarhus, Denmark) which hold records of following main variables: personal identification number, a unique sample identification number, requesting department, date and time of receipt and answering of samples, anatomical site, microbiological species, bacteria quantification if relevant, and freeze positions of all nasal swabs and *S. aureus* isolates.

The DBDSaCS database is stored on a specialized, secure section of the Danish National Supercomputer--Computerome (<http://www.computerome.dtu.dk>). The DBDSaCS database is updated on a quarterly basis with data exports from ProSang and MADS. At Computerome, the database is linked to data from all Danish blood donors (SCANDAT) and to data from the DBDS currently comprising 125,000 participants. Linkage to national health registers is already in place and updates to Denmark Statistics are performed as needed.

Statistics {#S0005-S2001}
----------

Characteristics of the cohort are presented as numbers, percentages, or medians, with interquartile ranges. Groups were compared by the two-sample *T*-test for normally distributed data, χ^2^ test, or Fisher's exact test for categorical data. Correlations between individual characteristics and *S. aureus* colonization were evaluated by log-binomial regression analysis adjusted for age, smoking status, BMI, and stratified by sex. Results were reported as risk ratios (RR) with 95% CI. Stata/IC 13.1 (StataCorp LP, College Station, Texas, USA) was used for statistical analysis.

First results {#S0006}
=============

In April 2019, the cohort comprised 6082 individuals ([Table 3](#T0003){ref-type="table"}): 44% women and 56% men. The overall prevalence of *S. aureus* nasal colonization was 41% and colonization was higher in men (46%) than women (34%) ([Table 4](#T0004){ref-type="table"}). The colonization rates of *S. aureus* for the 2217 participants sampled from the anterior nares, using the two-step method, are shown in [Table 5](#T0005){ref-type="table"}; the overall prevalence of *S. aureus* nasal colonization was 34% before and 41% after the use of enrichment broth. Table 3Characteristics of the DBDSaCS cohort by carrier status (n=6082)Total*S. aureus*-positive*S. aureus*-negativeN (%)60822488 (41)3594 (59)Age, years38.1 (26.9--50.6)36.6 (26.5--49.0)39.3 (27.5--51.3) 18--25997 (16)442 (44)555 (56) 26--351693 (28)729 (43)964 (57) 36--451206 (20)505 (42)701 (58) 46--551189 (20)460 (39)729 (61) 56--67997 (16)352 (35)645 (65)Women2683 (44)924 (34)1759 (66)Men3399 (56)1564 (46)1835 (54)Weight, kg^a^79 (70--89)80 (71--90)78 (69--88)Height, cm^b^177 (170--184)178 (172--185)176 (170--183)BMI, kg/m^2\ c^24.9 (22.7--27.5)25.1 (22.9--27.8)24.8 (22.6--27.2)BMI, categorized (kg/m2)^c^ BMI\<18.5, underweight (%)26 (0.4)12 (0.5)14 (0.4) 18.5≤BMI\<25, normal weight (%)3064 (51.1)1191 (48.5)1873 (53.0) 25≤BMI\<30, overweight (%)2167 (36.2)899 (36.6)1268 (35.9) BMI\>30, obese (%)734 (12.3)353 (14.4)381 (10.8)Current smoker (%)^d^739 (12.2)255 (10.3)484 (13.6)Short form-12^e^ Physical Component Score56.6 (54.0--57.9)56.9 (53.8--57.9)56.6 (54.0--57.9) Mental Component Score55.7 (52.3--57.7)55.7 (52.2--57.7)55.7 (52.3--57.7)[^5][^6]Table 4Characteristics of the DBDSaCS cohort by carrier status and stratified by sex (n=6082)WomenMenTotal*S. aureus*-positive*S. aureus*-negativeTotal*S. aureus-*positive*S. aureus*-negativeN (%)2683924 (34)1759 (66)33991564 (46)1835 (54)Age, years36.7 (25.7--50.2)31.3 (24.9--47.6)38.9 (26.3--51.2)39.1 (28.5--50.9)38.8 (28.0--49.8)39.3 (29.0--51.5) 18--25580 (22)234 (40)346 (60)417 (12)208 (50)209 (50) 26--35697 (26)275 (39)422 (61)996 (29)454 (46)542 (54) 36--45470 (18)146 (31)324 (69)736 (22)359 (49)377 (51) 46--55515 (19)155 (30)360 (70)674 (20)305 (45)369 (55) 56--67421 (16)114 (27)307 (73)576 (17)238 (41)338 (59)Weight, kg^a^70 (63--80)70 (64--80)70 (63--79)84 (76--93)85 (77--93)83 (76--92)Height, cm^b^170 (165--174)170 (165--174)170 (165--174)183 (178--187)183 (178--187)182 (178--187)BMI, kg/m^2\ c^24.3 (22.1--27.5)24.5 (22.1--27.9)24.2 (22.0--27.4)25.2 (23.3--27.4)25.4 (23.4--27.8)25.0 (23.1--27.2)BMI, categorized (kg/m^2^)^c^ BMI\<18.5, underweight (%)20 (0.8)7 (0.8)13 (0.8)6 (0.2)5 (0.3)1 (0.1) 18.5≤BMI\<25, normal weight (%)1464 (55.6)500 (55.2)964 (55.9)1600 (47.6)691 (44.6)909 (50.2) 25≤BMI\<30, overweight (%)775 (29.4)252 (27.8)523 (30.3)1392 (41.4)647 (41.8)745 (41.2) BMI\>30, obese (%)373 (14.2)147 (16.2)226 (13.1)361 (10.7)206 (13.3)155 (8.6)Current smoker (%)^d^312 (11.8)88 (9.6)224 (12.9)427 (12.6)167 (10.7)260 (14.2)Short form-12^e^ Physical Component Score56.6 (53.8--57.8)56.6 (53.8--57.8)56.6 (53.7--57.9)56.6 (54.1--57.9)56.6 (53.9--57.9)56.6 (54.2--57.9) Mental Component Score55.1 (51.2--57.7)55.0 (50.9--57.7)55.1 (51.2--57.7)55.8 (52.8--57.7)55.8 (52.8--57.7)55.8 (52.9--57.7)[^7][^8]Table 5Characteristics of participants sampled from the nose and using the two-step culture method (n=2217)WomenMenTotal*S. aureus*-positivePositive. after 1^st^ cultureAdditional positive after enrichment*S. aureus*-negativeTotal*S. aureus*-positivePositive. after 1^st^ cultureAdditional positive after enrichment*S. aureus*-negativeNumber of participants880303 (34)236 (27)67 (8)577 (66)1337611 (46)520 (39)91 (7)726 (54)Age\<2516974 (44)53 (31)21 (12)95 (56)16687 (52)76 (46)11 (7)79 (48)25≤age\<3523694 (40)71 (30)23 (10)142 (60)383172 (45)141 (37)31 (8)211 (55)35≤age\<4514652 (36)43 (29)9 (6)94 (64)297147 (49)127 (43)20 (7)150 (51)45≤age\<5517944 (25)39 (22)5 (3)135 (75)258113 (44)98 (38)15 (6)145 (56)Age≥5515039 (26)30 (20)9 (6)111 (74)23392 (39)78 (33)14 (6)141 (61)Age, years37.7 (26.1--50.9)30.0 (25.1--46.5)32.4 (25.3--47.1)28.0 (24.3--41.8)41.1 (26.8--52.5)39.1 (28.7--50.8)38.3 (28.0--49.4)38.9 (28.4--49.3)36.4 (26.7--49.4)39.9 (29.4--51.8)Weight, kg^a^69 (62--78)68 (62--78)68 (62--78)66 (59--79)69 (62--78)83 (76--92)84 (76--93)85 (76--93)83 (76--90)83 (76--91)Height, cm^b^169 (165--173)169 (165--172)169 (165--173)168 (164--171)169 (165--174)182 (178--187)182 (178--187)182 (178--187)183 (178--187)182 (178--187)BMI, kg/m^2\ c^24.0 (21.9--26.7)23.7 (21.7--26.5)23.7 (21.7--26.6)23.7 (21.6--25.5)24.2 (22.0--26.8)24.9 (23.1--27.2)25.1 (23.2--27.8)25.1 (23.2--28.1)25.1 (23.1--27.1)24.8 (23.1--26.9)Current smoker^d^117 (13.3)30 (9.9)24 (10.1)6 (9.0)72 (15.1)178 (13.3)76 (12.5)62 (12.0)14 (15.4)102 (14.1)[^9][^10]

On average, participants colonized with *S. aureus* in the nostrils were 1.82 years (95% CI: 1.14--2.51) younger than noncolonized participants. In both sexes, the prevalence of *S. aureus* colonization decreased with increasing age. Thus, the colonization proportion was 13 percentage points lower among women aged 55 years or older when compared to women below 25 years. Similarly, the colonization proportion was 9 percentage points lower among older men ([Table 4](#T0004){ref-type="table"}).

The prevalence of smoking in the cohort was 12.2%: 11.8% for women and 12.6% for men. The prevalence of *S. aureus* nasal colonization was 34.2% and 41.7% among smokers and nonsmokers, respectively. Obesity (BMI ≥30 kg/m^2^) was more prevalent among *S. aureus* colonized participants (14.4%) compared with non-carriers (10.8%) ([Tables 3](#T0003){ref-type="table"} and [4](#T0004){ref-type="table"}).

In comparison with the blood donors nationwide not participating in DBDSaCS, the median age and median hemoglobin are similar. The DBDSaCS cohort comprises a larger percentage of men and a smaller age group of 18--25 in return for a larger age group of 26--35. Also, DBDSaCS participants' number of donations during the previous 5 years are approximately one and a half-fold higher than blood donors not participating ([Table 1](#T0001){ref-type="table"}).

The effect of using a two-step culture method {#S0006-S2001}
---------------------------------------------

The effect of using enrichment broth is illustrated in [Table 5](#T0005){ref-type="table"}. In the 2217 individuals sampled from the nose using the two-step method, prevalence of *S. aureus* nasal colonization prior to and after enrichment was 34% and 41%, respectively. Enrichment broth increased the number of positive samples by 21%. The effect of using enrichment broth was higher for women when compared to men. We found that 8% of women were only positive after enrichment, corresponding to 24% of all *S. aureus*--positive women. In comparison, we found that 6% of men were positive only after enrichment corresponding to 14% of all *S. aureus--*positive men ([Table 5](#T0005){ref-type="table"}).

In both sexes, there was no difference between individuals positive for *S. aureus* after enrichment broth compared to individuals only positive after primary culture with respect to age, BMI, or smoking status.

The effect of including a throat swab {#S0006-S2002}
-------------------------------------

In the group of 262 participants swabbed in the nose and the throat, overall prevalence of *S. aureus* colonization prior to enrichment was 33% in the nares and 31% in the throat ([Table 6](#T0006){ref-type="table"}). The combined prevalence of *S. aureus* colonization sampled and cultured from the nares and the throat prior to enrichment was 45%. The combined prevalence of *S. aureus* colonization after enrichment was 55% with a higher prevalence of colonization in the throat (45%) than in the nose (40%) ([Table 6](#T0006){ref-type="table"}). Enrichment broth increased the number of *S. aureus* positive samples from both nose and throat swabs. However, the effect of using enrichment broth was more pronounced for throat than for nose swabs with an additional proportion of positive samples after enrichment of 43% and 23%, respectively. Table 6Prevalence of throat and nasal colonization after primary culture and after enrichment (n=262)Site of colonizationNo.%Additional proportion of positive samples after enrichment (%)*S. aureus*-positive in nares10640Before enrichment8633After enrichment20823*S. aureus*-positive in throat11745Before enrichment8231After enrichment351343*S. aureus*-positive in nares and/or throat14455Before enrichment11945After enrichment251021[^11][^12]

Correlation between individual characteristics and colonization {#S0006-S2003}
---------------------------------------------------------------

A characterization of the association between *S. aureus* colonization and age, BMI (categorized cf. WHO definition), and smoking status is presented in [Table 7](#T0007){ref-type="table"} with crude and adjusted RRs. In the adjusted model, 10-year older age was associated with lower risk of *S. aureus* colonization among both women (RR=0.87, 95% CI: 0.84--0.91) and men (RR=0.96, CI: 0.93--0.98) and the inverse association of age on nasal colonization was even stronger when comparing the oldest (55--67 years) and the youngest age group (18--25 years) (women: RR =0.66, CI: 0.55--0.79; men: RR=0.80, CI: 0.70--0.92). Similarly, current smoking status was associated with lower risk among both women (RR =0.78, CI: 0.64--0.93) and men (RR=0.83, CI: 0.73--0.94). Conversely, obesity was associated with the risk of *S. aureus* colonization in both genders (women: RR=1.22, CI: 1.06--1.41; men: RR=1.36, CI: 1.22--1.51). Table 7Predictors of *Staphylococcus aureus* colonization by log-binomial regression analysis (n=6082)^a^CharacteristicsWomenMenCrude modelAdjusted modelCrude modelAdjusted modelNumberRR95% CIRR95% CINumberRR95% CIRR95% CIAge, 10-year increment26830.880.85--0.920.870.84--0.9133990.970.94--0.990.960.93--0.9818--25580113961126--356970.980.85--1.120.970.85--1.119590.910.81--1.030.900.81--0.9936--454700.770.65--0.910.750.63--0.897040.980.87--1.100.950.84--1.0846--555150.750.63--0.880.720.61--0.856530.910.80--1.030.880.77--1.0056-674210.670.56--0.810.660.55--0.795590.830.72--0.950.800.70--0.92BMI (categorized), kg/m^2\ b^Normal weight (18.5≤BMI\<25)1464116001Underweight (BMI\<18.5)201.020.56--1.870.960.53--1.7461.931.34--2.771.801.25--2.59Overweight (25≤BMI\<30)7750.950.84--1.081.000.88--1.1313921.080.99--1.171.101.01--1.19Obese (BMI≥30)3731.151.00--1.331.221.06--1.413611.321.19--1.471.361.22--1.51Current smoking^c^Nonsmoker234111295611Smoker3120.800.66--0.960.780.64--0.934270.830.73--0.940.830.73--0.94[^13][^14]

In order to determine long-term *S. aureus* carriage status, multiple nasal swabs are collected randomly from donors returning to donate. A preliminary statement of carriership among participants with 2--5 samples is presented in [[Table S1]{.ul}](https://www.dovepress.com/get_supplementary_file.php?f=218637.xlsx).

Discussion {#S0007}
==========

In this cohort of healthy blood donors, we found that the overall prevalence of *S. aureus* colonization after enrichment was 41% for nasal carriage and 55% for nasal and/or throat carriage; men were more frequently colonized than women. *S. aureus* colonization was lower among older participants and smokers, whereas obesity was associated with an increased risk of colonization. The use of an enrichment broth increased the proportion of colonization especially among women and for throat carriage of *S. aureus*.

The prevalence of *S. aureus* nasal carriage in the general adult population varies according to population, the quality of sampling, and culture techniques.[@CIT0003],[@CIT0047] In sampling, culture, and identification of *S. aureus*, all our samples were cultured within 24 hrs using enrichment broth and a selective chromogenic media, which lowers the detection limit for *S. aureus*. Hence, we found that the overall prevalence of *S. aureus* after enrichment was 41%, slightly higher than the mean *S. aureus* nasal carriage rate of 37.2% (19.0--55.1), reported in selected cross-sectional studies of *S. aureus* nasal carriage in a review by Kluytman et al.[@CIT0048]

Other explanations for the high prevalence of *S. aureus* nasal carriage in our cohort could be the male/female ratio (men being more frequently culture-positive than women),[@CIT0049]--[@CIT0051] low prevalence of smoking (smokers are less frequent carriers of *S. aureus*),[@CIT0050],[@CIT0052] and age distribution (elderly are less frequently carriers).[@CIT0002] All these associations were confirmed in this study.

The *S. aureus* nasal carriage state can be predicted accurately by the use of quantitative and qualitative results from two swabs obtained at 1-week intervals.[@CIT0053] In the current study, the distribution between all positive samples, alternating samples, and all negative samples is in line with previously reported prevalences based on repeated nasal swabs obtained during the study period.[@CIT0002],[@CIT0053],[@CIT0054]

We found a significantly higher prevalence of *S. aureus* carriage among men (46%) than women (34%). Regarding the lower prevalence of colonization among women, a recent study by Liu et al using both culture and PCR methods showed that the difference in *S. aureus* prevalence between the culture of samples from women and men was most likely due to a lower number of *S. aureus* in the nares of women.[@CIT0055] This is in line with the findings in the current study where the effect of using enrichment broth was higher for women than men. The reason for this is not known, but could be related to anatomical and gender-dependent differences in the inner wall of a nostril that includes apocrine sweat glands, sebaceous glands, hair follicles, or sex hormones.[@CIT0056]

Regarding smoking, we hypothesize that the current decreasing prevalence of smoking in high-income countries could be associated with an increase in the prevalence of *S. aureus* colonization.

In the current study, *S. aureus* carriage increased with obesity. It has previously been reported that obesity was found to be a predictor for *S. aureus* nasal colonization, independent of diabetes, in particular among premenopausal women.[@CIT0027] Furthermore, in a previous study, we have shown that obesity among healthy individuals was associated with an overall increased risk of infection. Obesity was associated with an increased risk of abscesses, infections of the skin, and an increased risk of redeemed prescriptions for dicloxacillin and flucloxacillin[@CIT0042] We speculate that the higher risk of *S. aureus* carriage may contribute to the increased risk of *S. aureus--*related infections in obese participants.

Recently, several studies have highlighted the importance of throat colonization, and throat carriage has been reported to range between 30% and 47%.[@CIT0007][@CIT0009],[@CIT0047] In this study, we included a throat swab from a subpopulation. When using enrichment broth, the throat was a more common colonization site than the nose and when combined the prevalence of *S. aureus* in the nose and/or the throat increased to 55%. The use of enrichment broth increased the prevalence, especially in throat samples, possibly because of a lower number of *S. aureus* or sampling difficulties in the pharyngeal area. Our results confirm that sampling from more than one anatomical site and using enrichment broth more accurately detects colonization with *S. aureus.*

Strength and weaknesses {#S0008}
=======================

Blood donors are a highly selected, healthy population, simply because they comply with criteria regarding health status and lifestyle to be accepted as donors and for their further activity as blood donors. Also, blood donors are permanently excluded from blood donation if diagnosed with certain chronic diseases, including diabetes, hypertension, cancer, or hypercholesterolemia. This can be both an advantage and a limitation. Furthermore, persons weighing less than 50 kg cannot be blood donors. Thus, underweight people are underrepresented in our study. In a socio-demographic description of blood donors, we found that individuals with a low educational level (primary and lower secondary education) and low incomes are underrepresented in the donor populations as well as people of non-ethnic Danish origin and single men.[@CIT0057] Participants in DBDSaCS are similar in characteristics compared with blood donors not participating apart from being more actively bled during the previous 5 years before inclusion. This may reflect that DBDSaCS participants are a selected group of blood donors more willing to donate frequently or healthier in order to donate more; however, these factors do not affect the *S. aureus* colonization rates. We believe that the higher proportion of men in the DBDSaCS cohort is largely due to women more often being below the hemoglobin deferral guideline, thus affecting their possibility being included in DBDSaCS study.

Exclusively sampling from the nose, we miss participants that are carriers at other sites. However, throat swabs require more technical skills and results may thus depend on the skills of different health care workers.[@CIT0008] In DBDSaCS, participants are included while donating blood and, in this setting, a nasal swab was more feasible than a throat swab. Furthermore, exclusively sampling at a single point, we miss the ability to divide participants into persistent carriers, intermittent carriers, and noncarriers. However, this study already included a second swab for 1385 participants, and as this study is an ongoing large-scale study, we aim to include more than 20,000 blood donors. We include participants returning for blood donation and collect a second nasal swab for a large subgroup within the DBDSaCS.

Conclusion and perspectives {#S0009}
===========================

In conclusion, we report that *S. aureus* nasal colonization rates among Danish blood donors are in the upper range compared to previous European population--based studies. Using an enrichment broth increased the detection rate of *S. aureus* carriers and the effect was more pronounced for throat swabs and among women. Our findings support previously reported prevalences of *S. aureus* carriage types and determinants of *S. aureus* colonization, including smoking and aging that are inversely associated with colonization while male sex and obesity are positively associated with colonization. This underscores that the DBDSaCS is a feasible platform for future *S. aureus* carriage studies. Our study is unique as it includes only healthy blood donors complying with strict criteria to be allowed to donate blood. This minimizes effects from existing diseases and recent antibiotic treatment as impacting on the risk of both *S. aureus* carriage and subsequent infection. The participants are followed through the Danish national health registers with complete follow-up regarding contacts to hospitals and redeemed prescriptions. We will therefore over time be able to assess the impact of *S. aureus* carriage on the health of the participants. A number of projects using DBDSaCS data, as described above, have already been initiated in order to fulfill the primary objectives. Specifically, a follow-up study assessing the association between *S. aureus* nasal and/or throat carriage and the risk of infection with *S. aureus* or other infections is scheduled in spring 2020. Further, the association of carriage on, eg, diabetes, cardiovascular, and autoimmune diseases, will be addressed in future studies. The findings will be published in the years to come with the first publications being submitted in 2019.

Studying the association between *S. aureus* and genetic or environmental predictors may provide unique opportunities to understand key elements of the bacteria and the diseases that can follow. If an association exists, this knowledge might facilitate the discovery of new interventions against *S. aureus*.

Organization {#S0010}
============

The DBDSaCS is anchored in the DBDS. A growing number of large-scale population-based studies and epidemiological research have been conducted and published using data from the DBDS cohort. DBDS is managed by a steering committee and permanent staff capable of conducting large-scale data collection, analyses, and interpretation in the general population. In DBDSaCS, the principal investigators are Christian Erikstrup and Lise Tornvig Erikstrup who leads the coordination of projects and activities, including scientific, financial, ethics, and communication tasks. Also, Christian Erikstrup is a member of the steering committee in the DBDS making multidisciplinary projects between the DBDSaCS and the DBDS possible. The steering committee in DBDSaCS includes Professor Christian Erikstrup, staff physician Lise Tornvig Erikstrup, PhD fellow Khoa Manh Dinh, and Professor Paal Skytt Andersen with the responsibility of reviewing the scientific progress. Further, the steering committee can grant access to data and biological material based on submitted application accompanied by a research proposal that complies with Danish regulations on ethical approval and data protection.
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[^5]: **Notes:** Results are reported as medians (interquartile ranges), numbers (percentages). ^a^n=49 missing values; ^b^n=87 missing; ^c^n=91 missing; ^d^n=46 missing values; ^e^n=45.

[^6]: **Abbreviation:** BMI, body mass index.

[^7]: **Notes:** Results are reported as medians (interquartile ranges), numbers (percentages). ^a^n=49 missing values; ^b^n=87 missing; ^c^n=91 missing; ^d^n=46 missing values; ^e^n=45
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[^9]: **Notes:** Numbers with percentages or medians with interquartile ranges. ^a^n=2 missing values; ^b^n=33 missing; ^c^n=33 missing; ^d^n=2 missing values.

[^10]: **Abbreviation:** BMI, body mass index.

[^11]: **Note:** Numbers and percentages of samples positive for *S. aureus* among 262 participants with concomitant nasal and throat swabs.

[^12]: **Abbreviation:** No., number.

[^13]: **Notes:** Results presented as risk ratios (RR) with 95% CI. ^a^Log-binomial regression analysis of *S. aureus colonization* with age (10-year age-groups), body mass index (BMI) categorized cf. WHO definitions, and current smoking as predictors, stratified by sex. Crude model = univariate log-binomial regression without adjustment; adjusted model = based on the crude model with additional adjustment for age, BMI (continuous), and current smoking status. ^b^n=91 missing; ^c^n=46 missing values.
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